Insider Transactions in Q2 2021 at 9 Meters Biopharma, Inc. (NMTR)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Orbi Med Israel Gp Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,989,876
-65.12%
|
$15,989,876
$1.21 P/Share
|
|
Jun 24
2021
|
Orbi Med Israel Gp Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
319,255
-1.28%
|
$319,255
$1.38 P/Share
|
|
Jun 23
2021
|
Orbi Med Israel Gp Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
841,650
-3.27%
|
$841,650
$1.36 P/Share
|
|
May 11
2021
|
Orbi Med Israel Gp Ltd. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
31,944
+0.06%
|
$0
$0.66 P/Share
|
|
Apr 05
2021
|
Edward J Sitar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+21.8%
|
$50,000
$1.0 P/Share
|
|
Apr 05
2021
|
John Temperato Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+8.49%
|
$100,000
$1.0 P/Share
|
|
Apr 05
2021
|
Mark A Sirgo Director |
BUY
Open market or private purchase
|
Direct |
300,000
+21.83%
|
$300,000
$1.0 P/Share
|